We could not find any results for:
Make sure your spelling is correct or try broadening your search.
ITeos Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of immuno-oncology therapeutics for patients. Its product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoin... ITeos Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of immuno-oncology therapeutics for patients. Its product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody. Show more
SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...
SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...
SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...
SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...
SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...
LIMITED POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATIONS Know all by these presents, that the undersigned hereby constitutes and appoints Michel Detheux, Adi Osovsky and...
As filed with the Securities and Exchange Commission on March 6, 2024 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE...
0001808865falseFYhttp://fasb.org/us-gaap/2023#UsefulLifeShorterOfTermOfLeaseOrAssetUtilityMember2016-05-312021-12-312021-02-282030-01-312021-11-302027-02-280001808865us-gaap:CorporateDebtSecurities...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 2.4 | 21.5827338129 | 11.12 | 13.7 | 11.04 | 340288 | 12.21021244 | CS |
4 | 2.52 | 22.9090909091 | 11 | 13.7 | 10.2 | 266127 | 11.58735762 | CS |
12 | 2.27 | 20.1777777778 | 11.25 | 13.7 | 9.7 | 270549 | 10.92104606 | CS |
26 | 2.01 | 17.4630755864 | 11.51 | 13.7 | 8.2 | 376026 | 10.20772592 | CS |
52 | -0.13 | -0.952380952381 | 13.65 | 18.24 | 8.2 | 358028 | 11.85558769 | CS |
156 | -20.83 | -60.6404657933 | 34.35 | 52.43 | 8.2 | 363288 | 21.81303035 | CS |
260 | -6.18 | -31.3705583756 | 19.7 | 52.43 | 8.2 | 333563 | 22.83028903 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions